DCF — ST. JOSEPH MEDICAL CENTER
Enterprise Value: $-0.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-0.7M
Enterprise Value
$-19.8M
PV of Cash Flows
$19.1M
PV of Terminal Value
$30.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $772.5M | $18.6M | 2.0% | $-14.1M | $-12.8M |
| Year 2 | $795.6M | $27.1M | 3.0% | $-8.4M | $-6.9M |
| Year 3 | $819.5M | $36.1M | 4.0% | $-2.5M | $-1.9M |
| Year 4 | $844.1M | $41.4M | 5.0% | $0.6M | $0.4M |
| Year 5 | $869.4M | $44.8M | 5.0% | $2.3M | $1.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-0.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$750.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.019059383160650895
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5